Treatment as Prevention¨

CANOC fact sheet: Learn about the largest nationwide study of people living with HIV on treatment

This week, we are sharing a fact sheet on the Canadian Observational Cohort (CANOC): Canada’s largest multi-province study of people living with HIV on antiretroviral therapy. CANOC is an integrated network of all registered treatment information from eleven cohort databases across British Columbia, Ontario, Quebec, Saskatchewan and Newfoundland. This collaboration of national researchers and select databases establishes policy-relevant studies in HIV therapeutics, population and public health.

CANOC fact sheet: Learn about the largest nationwide study of people living with HIV on treatment Read More »

MOSH brings health care to people living on the streets, while Halifax faces HIV outbreak.

It’s a Thursday morning in March, and the red Toyota Sienna is ready to start on its route from the North End Community Health Centre on Gottingen Street through the streets of Halifax. To most, the van goes unnoticed. Besides the slightly raised ceiling, the only distinguishing feature on the van is a vanity plate

MOSH brings health care to people living on the streets, while Halifax faces HIV outbreak. Read More »

Scientists have found a way to completely stop the spread of HIV

The end of the era of AIDS can be a matter of time after a large-scale study of 1,000 males whose HIV infection was completely suppressed with antiretroviral drugs, didn’t infect their partners. “The success of the therapy means that if all HIV-positive people received treatment, further spread of the infection would not happen,” writes

Scientists have found a way to completely stop the spread of HIV Read More »

U=U vs. TasP

Undetectable equals Untransmittable/U=U vs. Treatment as Prevention (TasP). One has captured the imagination of people living with HIV (PLWH) around the world while the other seems to have disappeared. U=U was created by community to empower PLWH to have an undetectable viral load so they can’t transmit HIV. TasP was created by scientists to explain

U=U vs. TasP Read More »

Drugmaker Gilead Is Making HIV Prevention Meds More Accessible

Earlier this month, pharmaceutical company Gilead Sciences announced that it will donate enough HIV prevention drug Truvada to the Centers for Disease Control and Prevention (CDC) to benefit 200,000 people at risk for HIV. While news of the announcement was met positively, it also came ahead of some other negative headlines surrounding the drugmaker, coupled

Drugmaker Gilead Is Making HIV Prevention Meds More Accessible Read More »

Houston Health Department launches I am Life™ campaign to educate audiences about preventing HIV through PrEP, Treatment as Prevention (TasP) to end HIV transmission

A high number of HIV cases among the LGBTQ community’s African-American and Hispanic populations has become one of the top health crises in the Houston area and the southern United States. Specifically, the sub-groups at greater risk of acquiring HIV are African-American and Hispanic men who have sex with men (MSM) and transgender people of

Houston Health Department launches I am Life™ campaign to educate audiences about preventing HIV through PrEP, Treatment as Prevention (TasP) to end HIV transmission Read More »

Structure of T cell epitopes a decisive factor in natural HIV control, study finds

Researchers apply network theory to HIV protein structure, uncovering a vital link between connectivity and protective immune response. In 2017, nearly 37 million people were living with HIV worldwide, according to the Joint United Nations Program on HIV/AIDS (UNAIDS). Current treatments for the virus, which becomes AIDS in its most advanced stage, involve a combination

Structure of T cell epitopes a decisive factor in natural HIV control, study finds Read More »

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025